Arrowhead Pharmaceuticals
ARWR
#1920
Rank
$10.95 B
Marketcap
$77.74
Share price
6.96%
Change (1 day)
456.48%
Change (1 year)

P/S ratio for Arrowhead Pharmaceuticals (ARWR)

P/S ratio as of May 2026 (TTM): 10.0

According to Arrowhead Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 19.5. At the end of 2025 the company had a P/S ratio of 8.59.

P/S ratio history for Arrowhead Pharmaceuticals from 2001 to 2025

PS ratio at the end of each year

Year P/S ratio Change
20258.59-99.09%
20249445117.14%
202318.19.07%
202216.6-65.44%
202148.0-51.41%
202098.8151.89%
201939.261.22%
201824.3169.8%
20179.01-64.88%
201625.7-98.22%
2015> 10007.55%
2014> 1000-44.71%
2013> 10001936.39%
2012119-93.55%
2011> 100012700.49%
201014.439.13%
200910.3-57.95%
200824.6-72.88%
200790.6-78.6%
2006424111.8%
20052006.9%
2004187547.7%
200328.9126.56%
200212.7-11.98%
200114.5

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Johnson & Johnson
JNJ
5.53-44.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
9.52-5.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
16.5 64.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
8.87-11.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
640 6,275.36%๐Ÿ‡บ๐Ÿ‡ธ USA